NUTX

$94.01

Pre-MarketAs of Mar 17, 8:00 PM UTC

Nutex Health Inc.

Historical Price

Price (Line)
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

JNJUNHPFE

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$94.01
Potential Upside
232.1%
Whystock Fair Value$312.18
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorHealthcare
IndustryMedical Care Facilities

Nutex Health Inc. operates as a healthcare services and operations company in the United States. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The Hospital segment develops and operates a network o...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$664.83M
P/E Ratio
Value territory. Trading at a high yield relative to earnings.
8.97
Beta
High-beta play. Expect amplified moves vs. the broad market.
2.00
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Elite ROE. Management converts capital into profit efficiently.
58.94%
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
3.24

Recent News

GuruFocus.com
Mar 12, 2026

Nutex Health Inc (NUTX) Q4 2025 Earnings Call Highlights: Robust Annual Growth Amid Quarterly ...

Nutex Health Inc (NUTX) reports an impressive 82% annual revenue increase, despite facing a significant Q4 revenue reduction due to arbitration claims.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Simply Wall St.
Mar 9, 2026

Nutex Health (NUTX) Is Down 23.2% After Earnings Miss, IDR Issues, And New Buyback - What's Changed

Nutex Health reported full-year 2025 results on March 5, 2026, with revenue of US$875.26 million and net income of US$70.79 million, while Q4 earnings per share of US$1.61 came in well below expectations and revenue fell year-on-year. At the same time, the company disclosed IDR-related reimbursement issues that triggered legal scrutiny and paired them with completing one US$25 million buyback and authorizing another to offset dilution and signal confidence. We’ll now examine how the earnings...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
MT Newswires
Mar 6, 2026

Sector Update: Health Care Stocks Softer Late Afternoon

Health care stocks declined late Friday afternoon, with the NYSE Health Care Index and the State Str

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
MarketBeat
Mar 6, 2026

Nutex Health Q4 Earnings Call Highlights

Nutex Health (NASDAQ:NUTX) management highlighted sharp full-year revenue and earnings growth in 2025, improved cash generation, and continued progress navigating reimbursement under the Independent Dispute Resolution (IDR) process, while acknowledging a one-time fourth-quarter revenue reduction tie

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Barchart
Mar 6, 2026

Stocks Retreat Amid Inflation Fears and Weak US Jobs

The S&P 500 Index ($SPX ) (SPY ) today is down -0.95%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down -1.00%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.76%. March E-mini S&P futures (ESH26 ) are down -0.95%, and March E-mini Nasdaq futures...

BEARISH
Negative press. News cycle fixated on risk factors or misses.